The antibody purification services market is projected to be worth USD 2.02 billion by 2030, growing

Amidst the COVID-19 pandemic, there has been an evident surge in demand for standard quality antibodies for research, diagnosis and therapeutic purposes.
By: rootsanalysis
CORVALLIS, Ore. - Oct. 14, 2021 - PRLog -- London

Roots Analysis ( has announced the addition of "Global Antibody Purification ( Services Market, 2021 – 2030" report to its list of offerings.

Isolation and purification of antibodies, from different sources, including serum, ascites fluid and hybridoma cell culture, requires specialized equipment and focused expertise; as a result, drug developers and academic institutions outsource various aspects of downstream processing, including antibody purification to contract service providers, that claim to have the required capabilities for purification of antibodies in minimum time with reduced chances of failure.

To order this 270+ page report, which features 100+ figures and 130+ tables, please visit


Key Market Insights

More than 150 players claim to offer services for purification of antibodies

The market is predominantly characterized by the presence of small firms (having less than 50 employees). It is worth noting that more than 75% of the players purify antibodies isolated from serum, followed by hybridoma cell culture supernatant (58%). Further, more than 30% players provide purification services for both monoclonal and polyclonal antibodies.

Over 80% antibody purification service providers are based in North America and Europe

Within North America, majority (91%) of the players are headquartered in the US, whereas in Europe, most of the companies are based in the UK (17), Germany (11), France (11) and Sweden (5).

Presently, more than 100 players use class-specific methods to isolate specific antibody isotypes

Most of the players use Protein A and Protein G resin, for affinity column chromatography. Of the players using physico-chemical antibody purification methods, majority (77%) employ ion exchange chromatography, followed by size exclusion chromatography.

The demand for purified antibodies is expected to grow to over 47,000 Kg, till 2025

Currently, North America is estimated to contribute to nearly 50% of the overall purification demand for clinical and commercial- grade therapeutic antibodies. By 2025, the global demand for approved / marketed antibodies is estimated to grow to over 42,000 Kg, primarily driven by the anticipated growth in the sales of monoclonal antibody products.

Start- ups / small firms are expected to capture nearly 40% share of the market share by 2030

With regard to the regional distribution, Europe is anticipated to contribute to more than 70% of the total service revenues generated in 2030. In the long term, physico-chemical purification is likely to become the preferred choice for antibody purification service providers; projects involving the aforementioned technique are expected to capture majority share (40%) of the total market.

For additional details, please visit


Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Location:Corvallis - Oregon - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share